Get the Weekly Intelligence Brief — top committee picks every Sunday.
BN · NYSE · STOCK

Brookfield (BN) Stock Analysis

Financial Services Updated October 10, 2026
$37.09
52W $35.69 – $49.57
52/100
$82.84B
66.1
1.82
AI Committee Verdict
Watch
52/100
Conviction: Contested · 50% agreement · 6 analysts
+8.2%
-21.6%
0.38:1
Contested

Is BN Bullish or Bearish?

Mixed. Innellis AI committee rates Brookfield Corporation (BN) Watch with a composite score of 52/100 , based on 6 analysts with 50% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +8.49 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -11.51 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • EPS growing 68.0% YoY — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • P/E of 63.6 is expensive by classic value standards — Value
  • ROE of only 3.0% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 5.69 adds balance-sheet risk to the value case — Value
  • Price structure making lower highs and lower lows — Technical
  • Daily trend (downtrend) conflicts with the weekly trend (uptrend) -- fighting the larger trend — Technical
  • Weekly RSI at 23 -- oversold on the larger timeframe too — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
52/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 92%
of 211 Financial Services peers
Value Analyst bearish
35 / 100 · High confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 63.6 is expensive by classic value standards
Growth Analyst bullish
62 / 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ EPS growing 68.0% YoY
Technical Analyst neutral
46 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Risk Analyst neutral
45 / 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
− High leverage (debt-to-equity 5.69) amplifies downside in a stress scenario
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
55 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 49.4 to 51.5.

Analyst-level changes:
  • Risk Analyst: stance bearish->neutral; score 32->45 (+12).
  • Technical Analyst: +1 bearish signal(s).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
49.6
Neutral
MACD Histogram
0.214
Bullish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Mixed
Support
$29.09
Resistance
$40.13
Bollinger %B
0.53
Inside Bands
Price vs Moving Averages
EMA 9
$36.95 Above
EMA 21
$37.50 Below
EMA 50
$39.23 Below
EMA 200
$42.20 Below

Fundamental Analysis

Valuation
65
Growth
61
Profitability
12
Financial Health
14
Cash Flow
15
Valuation
P/E Ratio 66.1×
P/B Ratio 1.89×
PEG Ratio 0.76
Dividend Yield 0.73%
52W High $49.57
52W Low $35.69
Quality & Growth
ROE 273.4%
ROA 25.2%
Gross Margin 2876.4%
Operating Margin 2856.2%
Revenue Growth YoY —
Debt / Equity 5.69
AI Fundamental Assessment
P/E ratio of 66.1 (rich relative to a 15-40x range); Price-to-book of 1.9x; PEG ratio of 0.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 2.7%; Return on assets of 0.3%; Net margin of 1.8%; Gross margin of 28.8%; Current ratio of 1.14 (tight short-term liquidity); Debt-to-equity of 5.69; Free cash flow per share is negative (-3.50); Most recent quarter missed estimates by 1.0%; EPS growth roughly steady (-1.5% -> +0.0% QoQ); Average YoY EPS growth of 12.5%; Analyst estimates rising over recent quarters
Get the Full BN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime